ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2015 American Transplant Congress

    A Prospective Pilot Study Evaluating the Safety and Efficacy of Everolimus for the Prevention of CMV and BK Viral Infection (BKV) in Broadly Sensitized Kidney Transplant Recipients Following Desensitization With IVIG and Rituximab: Interim Analysis

    J. Kahwaji,1 S. Louie,1 A. Vo,1 J. Choi,1 M. Toyoda,2 S. Ge,2 P. Wongsaroj,1 A. Peng,1 R. Villicana,1 S. Jordan.1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; 2Transplant Immunology Lab, Cedars-Sinai Medical Center, Los Angeles, CA.

    Introduction: Everolimus, a second generation mTOR inhibitor, may prevent CMV and BKV infection after kidney transplantation. Broadly sensitized patients are at greater risk of viral…
  • 2015 American Transplant Congress

    Improving Latent Tuberculosis Diagnosis Before Kidney Transplantation in a Developing Country

    G. Meinerz,1,2 C. da Silva,1,2 E. Keitel,1,2 A. Pasqualotto,3 J. Goldani,1,2 C. Zeni,1,4 F. Vacilotto,1,4 N. Prado,1,4 A. Monteiro,2,3 D. Seelig,1 F. Klaus,1 J. Andrade,1 V. Garcia.1

    1Nephrology and Kidney Transplantation, Irmandade Santa Casa de Misericordia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande do Sul, Brazil; 2Programa de Pós-Graduação em Patologia, Universidade Federal de Ciencias da Saude de Porto Alegre - UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil; 3Laboratorio de Biologia Molecular, Irmandade Santa Casa de Misericordia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande do Sul, Brazil; 4Programa de Residência em Nefrologia, Universidade Federal de Ciencias da Saude de Porto Alegre - UFCSPA, Porto Alegre, Rio Grande do Sul, Brazil.

    Introduction: Tuberculosis has shown to be a great challenge in kidney transplantation, specially in developing countries due to the difficulties in diagnosis and treatment, leading…
  • 2015 American Transplant Congress

    Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir

    S. Dulanya, A. Anamisis, D. Tsapepas.

    Department of Pharmacy, New York Presbyterian Hospital, New York City, NY.

    Cytomegalovirus (CMV) is an opportunistic infection responsible for profound morbidity and mortality among solid organ transplant recipients. A donor and recipient's CMV IgG serostatus influences…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences